Available IPD datapackage for study 'A Placebo-Controlled Double-Blind Comparative Study of CNTO1275 in Patients With Plaque Type Psoriasis'

The purpose of this study is to evaluate the safety and efficacy of ustekinumab (CNTO 1275) compared with placebo in participants with moderate to severe plaque type psoriasis.

本研究旨在对比安慰剂，评估乌司奴单抗（ustekinumab，CNTO 1275）用于中重度斑块型银屑病受试者时的安全性与有效性。